ncRNA name
hsa-miR-34a
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
OAZ2
Cancer name
Colon Cancer
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Oxaliplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Up
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
We further confirmed that clinical CCa samples with lower miR-34a expression appeared to be more resistant to chemotherapy.
Tissue resource
colon tissues and adjacent normal colon tissues
human colorectal adenocarcinoma cell lines HCT-8
None
None
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
First Affiliated Hospital of Medical College of Shihezi University
American Type Culture Collection
Country
China
USA
Continent
Asia
North American